FDA Approved Linzess Capsules For Pediatric Patients 7 Years And Older With Irritable Bowel Syndrome With Constipation; Linzess Recommended Dosage For Pediatric Patients 7 Years And Older With IBS-C Is 145 mcg Orally Once Daily
Benzinga Newsdesk 1 year ago
BiotechNewsFDAGeneral
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-1st-drug-children-7-years-and-older-irritable-bowel-syndrome-constipation